Wednesday, February 25, 2009

Ranbaxy’s FDA Problems Cause Headaches for Daiichi Sankyo

The FDA accused Ranbaxy of falsifying data, the latest in a stream of problems since Daiichi Sankyo's bid for control of the generics maker.
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)